Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib

Circulation. 2002 Jul 30;106(5):e18. doi: 10.1161/01.cir.0000023454.92028.12.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aspirin / administration & dosage
  • Cardiovascular Diseases / chemically induced*
  • Controlled Clinical Trials as Topic / methods
  • Controlled Clinical Trials as Topic / standards
  • Cyclooxygenase Inhibitors / adverse effects*
  • Humans
  • Lactones / adverse effects*
  • Reproducibility of Results
  • Research Design / standards
  • Sulfones
  • Thrombosis / chemically induced

Substances

  • Cyclooxygenase Inhibitors
  • Lactones
  • Sulfones
  • rofecoxib
  • Aspirin